SARS-CoV-2 B.1.617 Mutations L452R and E484Q Are Not Synergistic for Antibody Evasion - Ferreira, Isabella A T M; Kemp, Steven A; Datir, Rawlings; Saito, Akatsuki; Meng, Bo; Rakshit, Partha; Takaori-Kondo, Akifumi; Kosugi, Yusuke; Uriu, Keiya; Kimura, Izumi; Shirakawa, Kotaro; Abdullahi, Adam; et al. (The Journal of infectious diseases, 2021)
Keywords: Angiotensin-Converting Enzyme 2; Animals; Antibodies; Antibodies, Neutralizing - immunology; Antibodies, Viral - blood; Antibodies, Viral - immunology; BNT162 Vaccine; Chlorocebus aethiops; COVID-19 - immunology; COVID-19 - virology; COVID-19 Vaccines - immunology; HEK293 Cells; Humans; Immune Evasion; India; Major and Brief Reports; mRNA; Mutation; Protein Binding; SARS-CoV-2 - genetics; SARS-CoV-2 - immunology; Serine Endopeptidases; Severe acute respiratory syndrome coronavirus 2; Spike Glycoprotein, Coronavirus - chemistry; Spike Glycoprotein, Coronavirus - genetics; Spike Glycoprotein, Coronavirus - immunology; Vaccines; Vero Cells; India; antibody escape; COVID-19; B.1.617; SARS-CoV-2; fitness; Indian variant; neutralizing antibodies; evasion; spike mutation; infectivity; resistance